Slingshot members are tracking this event:
Arrowhead Pharmaceuticals Initiates Phase 1/2 Single and Multiple Dose Study of Hepatitis B Candidate ARC-521
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Jun 09, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Hepatitis B, Arc-521, Chronic Hbv, Hbv, Hepatitis B Virus